medigraphic.com
Academia Mexicana de Neurología, A.C.

2013, Número 1

<< Anterior Siguiente >>

Rev Mex Neuroci 2013; 14 (1)


Lipofuscinosis neuronal ceroidea infantil tardía: Reporte de un caso

Andrade-Bañuelos A, Jean-Tron G, Ortega-Ponce F, Arnold S, Rana S, Islas-García D

Idioma: Español
Referencias bibliográficas: 32
Paginas: 44-49
Archivo PDF: 399.14 Kb.


RESUMEN

Englobadas dentro de las epilepsias mioclónicas progresivas, las lipofuscinosis neuronales ceroideas son un padecimiento comúnmente pediátrico y poco frecuente de desórdenes hereditarios que conducen a regresión en el neurodesarrollo, ataxia y muerte temprana. Existen ocho tipos conocidos de mutaciones genéticas que causan esta patología, el diagnóstico es clínico en primera instancia y se corrobora mediante estudios de imagen como la tomografía computarizada y la resonancia magnética, así como hallazgos en el electroencefalograma. Las tinciones de biopsia de tejidos y la microscopía electrónica proporcionan una excelente herramienta auxiliar. En este artículo presentamos el caso de un niño de cuatro años de edad al que mediante las manifestaciones clínicas: semiología de las crisis epilépticas y aparición cronológica de las mismas, regresión en el neurodesarrollo, hallazgos en neuroimagen, neurofisiológicos y de patología se logró confirmar el diagnóstico de lipofuscinosis neuronal ceroidea del tipo infantil tardío.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wisniewski KE, Kida E, Connell F, Zhong N. Neuronal ceroid lipofuscinoses: research update. Neurol Sci 2000; 21(3 Suppl.): S49-56.

  2. Berkovic SF, Cochius J, Andermann E, Andermann F. Progressive myoclonus epilepsies: clinical and genetic aspects. Epilepsia 1993; 34(Suppl. 3): S19-30.

  3. Zeman W, Dyken P. Neural Ceroid Lipofuscinosis: Relationship to amaurotic family idiocy? Pediatrics 1969; 44: 570-83.

  4. Goebel HH. The neuronal ceroid-lipofuscinoses. J Child Neurol 1995; 10: 424-37.

  5. Williams R, Vesa J, Järvelä I, McKay T, Mitchison H, Hellsten E, Thompson A, Callen D, Sutherland G, Luna-Battadano D, et al. Genetic heterogeneity in neuronal ceroid lipofuscinosis (NCL): evidence that the late-infantile subtype (Jansky-Bielschowsky disease; CLN2) is not an allelic form of the juvenile or infantile subtypes. Am J Hum Genet 1993; 53: 931-5.

  6. Wilkinson ME. Ceroid lipofuscinosis, neuronal 3, Juvenile-Batten disease: case report and literature review. Optometry 2001; 72: 724-8.

  7. Schulz A, Dhar S, Rylova S, Dbaibo G, Alroy J, Hagel C, Artacho I, Kohlschutter A, Lin S, Boustany RM. (2004) Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Ann Neurol 56: 342-50.

  8. Shinnar S. The new ILAE classification. Epilepsia 2010; 51: 715-7.

  9. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, Van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology. Epilepsia 2010; 51: 676-85.

  10. Zeman W, Donahue S, Dyken P, Green J. The neuronal ceroid-lipofuscinoses. In: Vinken PJ, Bruyn GW ( eds.). Handbook of clinical Neurology. Vol. 10. Amsterdam: North Holland; 1970, p. 588-679.

  11. Aberg L. Juvenile Neural ceroid lipofuscinosis; Brain-Related symptoms and their treatment. Academic Dissertation, Faculty of Medicine of the University of Helsinki 2001.

  12. Järvelä I, Schleutker J, Haataja L, Santavuori P, et al. Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics 1991; 9(1): 170-3.

  13. Santavuori P. Neural ceroid lipofuscinoses in Childhood. Brain Dev 1988; 10: 80-3.

  14. Williams RE. NCL incidence and prevalence: what do we know? Presented at the 12th International Congress on Neuronal Ceroid Lipofuscinosis; June 3- 6, 2009; Hamburg, Germany.

  15. Wisniewski KE, Zhong N, Philippart M. Pheno/genotypic correlations of neuronal ceroid lipofuscinoses. Neurology 2001; 57: 576-81.

  16. Jansky J. Dosud nepopsan p Image ipad familiárni amaurotické idiotic kompliklované s hypoplasii moze Image kovou. Sborn Lék 1908; 13: 165-96.

  17. Bielschowsky M. Über spat-infantile familiäre amaurotische Idiotic mit Kleinhirnsymptomen. Dtsch Z Nervenheilk 1913; 50: 7-29.

  18. Goebel HH, Wisniewski KE. Current state of clinical and morphological features in human NCL. Brain Pathol 2004; 14: 61-9.

  19. Boustany RM. Neurology of the neuronal ceroidlipofuscinoses: late infantile and juvenile types. Am J Med Genet 1992; 42: 533-5.

  20. Sleat DE, Gin RM, Sohar I, et al. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet 1999; 64: 1511-23.

  21. Ramachandran N, Girard JM, Turnbull J, and Minassian BA. The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 2009; 50(Suppl. 5): 29-36.

  22. Rapola J, Salonen R, Ammala P, et al. Prenatal diagnosis of the infantile type of neuronal ceroid lipofuscinosis by electron microscopic investigation of human chorionic vili. Prenat Diagn 1993; 10: 553-9.

  23. Pampiglione G, Harden A. Neurophysiological identification of a late infantile form of neuronal lipidosis. J Neurol Neurosurg Psychiatry 1977; 36: 323-30.

  24. Tackmann W, Kuhlendahl D. Evoked potentials in neuronal ceroid lipofuscinosis. Eur Neurol 1979; 18: 234-42.

  25. Mrak RE. The Big Eye in the 21st Century: The Role of Electron Microscopy in Modern Diagnostic Neuropathology. J Neuropathol Experiment Neurol 2002; 61(12): 1027-39.

  26. Wisniewski KE, Zhong N. Philippart M. Pheno/genotypic correlations of neuronal ceroid lipofuscinoses. Neurology 2001; 57: 576-81.

  27. Alroy J, Ucci AA, Pfannl R. Why skin biopsy is useful for the diagnosis of lysosomal storage diseases. Current Medical Literature: Lysosomal Storage Disease 2006; 5: 70-6.

  28. Lönnqvist T, Vanhanen SL, Vettenranta K, et al. Hematopoietic stem cell transplantation in infantile neuronal ceroid lipofuscinosis. Neurology 2001; 57: 1411-16.

  29. Lake BD, Steward CG, Oakhill A, et al. Bone marrow transplantation in late infantile Batten disease and juvenile Batten disease. Neuropediatrics 1997; 28: 80-1.

  30. Hannah M. Mitchison and Sara E. Mole. Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease) Curr Opin Neurol 2001: 14: 795-803.

  31. Wong AM, Rahim AA, Waddington SN, Cooper JD. Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis. Biochem Soc Trans 2010; 38: 1484-8.

  32. Mole SE, Williams RE. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds.). Neuronal Ceroid-Lipofuscinoses. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2001 Oct 10 [updated 2010 Mar 02].




2020     |     www.medigraphic.com